Actinium Pharmaceuticals Inc (AMEX:ATNM)
$ 1.83 -0.1 (-5.18%) Market Cap: 57.09 Mil Enterprise Value: -24.06 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 27/100

Actinium Pharmaceuticals Inc SIERRA Late-Breaker Presentation at TCT - Corporate Call Transcript

Feb 18, 2023 / 11:00PM GMT
Operator

Presentation at TCT - Corporate Call
Feb 18, 2023 / 11:00PM GMT

=====================
Corporate Participants
=====================
* Sandesh Seth
Actinium Pharmaceuticals, Inc. - CEO & Chairman of the Board
* Madhuri Vusirikala
Actinium Pharmaceuticals, Inc. - VP, Clinical Development, Transplants and Cell Therapy
* Avinash Desai
Actinium Pharmaceuticals, Inc. - Chief Medical Officer
* Caroline Yarbrough
Actinium Pharmaceuticals, Inc. - Chief Commercial Officer

=====================
Conference Call Participants
=====================
* Kristen Kluska
Cantor Fitzgerald, L.P. - Analyst
* Joe Pantginis
H.C. Wainwright & Co., LLC - Analyst
* Yuan Zhi
B. Riley Securities, Inc. - Analyst
* Justin Walsh
JonesTrading Institutional Services LLC - Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot